More specifically, it was reported that IL-13 is produced by malignant lymphoma cells and acts as an autocrine factor regulating tumor cell proliferation through IL-13R signaling in both CTCL skin lesions and SCs in blood [42]. Here, IL13 is linked to neoplasm.